Vertex Pharmaceuticals, Inc. (VRTX) Latest News and Helpful Information

Vertex Pharmaceuticals, Inc. (VRTX) saw an uptrend of 0.87% in the recent trading with $415.71 being its most recent. The current price level -7.29% lower than the highest price of $448.40 marked by the stock while trading over the past 52-weeks, whereas it is 39.62% higher than the lowest price of $297.75 the company dropped […]

What Are Analysts and Indicators Saying About Vertex Pharmaceuticals, Inc. (VRTX)

Vertex Pharmaceuticals, Inc. (VRTX) saw downtrend of -1.07% in the recent trading with $408.77 being its most recent. The current price level -8.84% lower than the highest price of $448.40 marked by the stock while trading over the past 52-weeks, whereas it is 40.64% higher than the lowest price of $290.66 the company dropped to […]

What Do Analysts Say About Vertex Pharmaceuticals, Inc. (VRTX)?

Vertex Pharmaceuticals, Inc. (VRTX) saw downtrend of -0.86% in the recent trading with $411.85 being its most recent. The current price level -8.15% lower than the highest price of $448.40 marked by the stock while trading over the past 52-weeks, whereas it is 45.22% higher than the lowest price of $283.60 the company dropped to […]

What Are Analyst Opinions Regarding Vertex Pharmaceuticals, Inc. (VRTX)?

Vertex Pharmaceuticals, Inc. (VRTX) saw downtrend of -1.46% in the recent trading with $420.74 being its most recent. The current price level -6.17% lower than the highest price of $448.40 marked by the stock while trading over the past 52-weeks, whereas it is 48.36% higher than the lowest price of $283.60 the company dropped to […]

Vertex Pharmaceuticals, Inc. (VRTX): The stock medium term indicators say Buy today

Vertex Pharmaceuticals, Inc. (VRTX) saw an uptrend of 1.70% in the recent trading with $426.78 being its most recent. The current price level -4.82% lower than the highest price of $448.40 marked by the stock while trading over the past 52-weeks, whereas it is 50.49% higher than the lowest price of $283.60 the company dropped […]